Regulation For Tissue-Engineered Products Moves Forward In Europe
This article was originally published in The Gray Sheet
Executive Summary
Manufacturers of some tissue-engineered products on the European market would have four years to comply with a new regulation working its way through the European Union legislative process
You may also be interested in...
European Regulatory Round-Up: EMA And The UK Heed The Calls Of Industry; France Is Otherwise Occupied
The European Medicines Agency follows through on its transparency initiative with comprehensive list of products under review and also reduces pharmacovigilence data reporting requirements.
Industry-Supported Tissue, Device Regs Clear European Union Council
The second of two European Union legislative bodies endorsed two regulations impacting medical device oversight last week
Industry-Supported Tissue, Device Regs Clear European Union Council
The second of two European Union legislative bodies endorsed two regulations impacting medical device oversight last week